hypertension的例句大全

Inherited style of primary hypertension was not autosomal dominant inheritance are autosomal recessive inheritance.

不属于常染色体显性或隐性遗传方式。

Conclusion: The essential hypertension is the human phenotype blemish caused by injured DNA. It is compatible with an autosomal dominant inheritance and its performance is delayed.

结论原发性高血压是由DNA损伤引起的人类表型缺陷，该病症符合常染色体显性遗传，具延迟外显性。

Influence of Treatment for Hypertension With Atenolol on Triglyceride and High Density Lipoprotein

阿替洛尔治疗高血压对甘油三脂及高密度脂蛋白的影响

Long-term Treatment of Hypertension with Atenolol and Nifedipine& Echocardiographic Follow-up Study

氨酰心安和硝苯吡啶治疗高血压的疗效和超声心动图随访观察

Assessment of bisoprolol and atenolol in treatment of hypertension by ambulatory blood pressure monitoring

动态血压监测方法评价比索洛尔及阿替洛尔的降压疗效

A Study of the Relationship between Hemorheology of Pregnancy induced Hypertension and the Blood Flow Velocity of the Fetal Ascending Aorta

妊高征血液流变学与胎儿升主动脉平均血流速度相关性研究

A Study on Risk Factors of Benign Arteriolar Nephrosclerosis in Elderly Patients with Essential Hypertension

老年高血压病患者良性小动脉性肾硬化症危险因素分析

Ventricular arrhythmias in the hypertension patients with left ventricular hypertrophy

左室肥厚的高血压病患者的室性心律失常

Objective To explore the mental condition, and personality of patients with primary hypertension.

目的了解原发性高血压患者心理状况及个性特征.

Relationship between anoxemia and rennin-angiotension-aldosterone system in hypertension patients associated snoring

高血压伴鼾症低氧血症与血浆肾素血管紧张素及醛固酮的关系

Pathogenesy of hypertension LVH is extremely complicated, referring to many pathological and physiological mechanism. It has been confirmed that angiotonin II 1 receptor ( AT1R) plays a very important role in multiple factors.

由于高血压左室肥厚的发病机制非常复杂，涉及到许多病理生理机制，现已证实，在引起LVH的诸多因素中，血管紧张素Ⅱ1型受体（AT1R）发挥重要作用。

The Genetic Relationship Among Essential Hypertension, Plasma Renin Activity and Angiotensinogen

原发性高血压与血浆肾素活性及血管紧张素原遗传关系研究

Detection of angiotensinogen gene polymorphism and plasma NO and endothelin in patients with essential hypertension

原发性高血压患者血管紧张素原基因多态性及血浆NO、内皮素水平检测

Anamnesis information: hypertension, diabetes, hyperlipidemia, coronary heart disease, stroke history, dyslipidemia, smoking history, intervention of drugs ( antihypertensive agents, antiplatelet drugs, insulin, hypoglycemic drugs). 5.

既往病史：高血压、糖尿病、冠心病、脑卒中、血脂异常、吸烟史、药物干预情况（抗血小板聚集、胰岛素、降糖药、降压药使用）。

Comparison between amiloride and triamterene in treatment of 545 patients with essential hypertension

阿米洛利与氨苯蝶啶治疗原发性高血压545例的比较

The clinical effect of treating hypertension aircrew by diet and exercise intervention

饮食和运动干预治疗飞行人员高血压病的临床效果

The research headway of neuroimmunoendocrinology provides the new clue for acquainting hypertension.

神经免疫内分泌学的研究进展为认识高血压提供了新的线索。

Joined treatment of bypath and disconnection for hepatocirrhosis with portal hypertension bleeding

分流断流联合术治疗肝硬化门脉高压症出血

Conclusion By mastering a good indication, developing joined treatment of bypath and disconnection in some degree have complementary advantages which are an ideal treatment for portal hypertension bleeding.

结论：掌握好适应证开展分流加断流联合手术，在一定程度上能使二者优势互补，是一种理想的治疗门静脉高压症出血的术式。

Objective To analyze the advantage and disadvantage of bypath and disconnection, research on the complementary advantages of joined treatment of bypath and disconnection, and the clinical application of treating portal hypertension bleeding.

目的：分析分流术、断流术的利与弊，探讨分流断流联合术式优势互补，治疗门静脉高压症出血的临床疗效。